SAKARPharmaceuticals
Sakar Healthcare Ltd — Quarterly Results & Earnings
₹498.45
-2.69%
Profit Growth YoY-5.42%Latest quarter
Sales Growth YoY34.55%Latest quarter
Sales CAGR 5Y16.43%5 year compound
Profit CAGR 5Y12.94%5 year compound
📋
Quarterly Performance
YoY Profit Growth-5.42%
⚠️ Mild contraction
YoY Sales Growth+34.55%
🔥 Exceptional growth
OPM 5Y Average
25.29%Operating profit margin
EPS Growth 5Y
4.60%Interest Coverage
3.46Higher = safer debt servicing
ROE
6.48%ROCE
8.54%💡
Growth Analysis
Sakar Healthcare Ltd reported YoY profit growth of -5.42% and revenue growth of 34.55% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 16.43% and profits at 12.94% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Sakar Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.